Follow Us on Google
By Rita Okoye
In the global fight against the COVID-19 pandemic, Nigerian-born physician and epidemiologist Dr. Mary Oluwadunsin Oyeleke has emerged as one of the foremost voices exploring innovative solutions rooted in indigenous knowledge. On September 1, 2020, her landmark publication, “A Systematic Review on COVID-19 Pandemic with Special Emphasis on Curative Potentials of Nigeria-Based Medicinal Plants” was released, highlighting the urgent need for effective therapeutic strategies against SARS-CoV-2.
Dr. Oyeleke, an internationally trained medical doctor with advanced expertise in epidemiology and infectious diseases, is recognized as a scholar working at the cutting edge of public health research. With the world grappling with high mortality rates and no universally effective treatment, her work has drawn international attention for bridging rigorous scientific methods with the rich pharmaco-botanical traditions of Nigeria.
Other News
In her paper, Dr. Oyeleke and co-authors systematically examined the mechanisms of COVID-19 progression—hyper-inflammation, immunosuppression, and multi-organ failure—and proposed pharmacological pathways through which Nigeria-based medicinal plants could mitigate these effects. “Despite the frightening mortality rate associated with COVID-19, there is no known approved drug to effectively combat the pandemic,” the abstract reads, underscoring the global urgency that informed the study.
What sets Dr. Oyeleke apart is her unique academic journey. Before entering medicine, she trained as a botanist, developing a deep understanding of plant biology and pharmacognosy. Today, she brings that foundational expertise into her clinical and epidemiological work, combining laboratory science, clinical knowledge, and public health strategies. This multidisciplinary approach allows her to make contributions that are both innovative and impactful, particularly in a pandemic era where global health systems are stretched to their limits.
Her influence on infectious disease response is not new. In 2019, she authored “Evaluating the Public Health Response to Emerging Infectious Diseases: Lessons from the 2014–2016 West African Ebola Outbreak,” a study that examined global preparedness gaps and highlighted frameworks for stronger response systems. That work continues to be cited as a benchmark for shaping outbreak preparedness, and it laid the foundation for her present COVID-19 research.
Beyond her publications, Dr. Oyeleke’s leadership in infection control has already shaped national health policy: her infection control manual was recently adopted by the Ministry of Health, becoming a national reference tool for strengthening pandemic preparedness and response.
Peers and international observers describe her as a researcher at the top of her field, contributing original, high-impact work that is influencing new lines of inquiry in infectious disease therapeutics. Her leadership in evaluating the curative potentials of Nigeria’s medicinal plants positions her as both a scientist of global relevance and a champion of African innovation in medicine.
The publication not only adds to the global body of COVID-19 research but also places Nigeria on the map as a hub of scientific contributions rooted in traditional knowledge and modern medical science. It further underscores the potential for African scholars to influence the trajectory of global health research through rigorous and culturally contextualized inquiry.
Dr. Oyeleke’s work exemplifies how cutting-edge science can draw upon local resources to tackle international crises, reflecting her enduring commitment to advancing health equity, infectious disease prevention, and innovative therapeutics.
